Samsung Biologics labor dispute

The labor union at Samsung Biologics has entered a period of heightened industrial action following failed negotiations regarding wage increases and performance bonuses. The dispute involves a gap between the company’s proposed 6.2% base pay increase and the union’s demand for a 9.5% increase, plus bonuses tied to operating profits.

The conflict has expanded to include legal challenges regarding employer status. The union has demanded collective bargaining with Samsung Electronics, arguing that the latter acts as the practical employer due to its 31.22% stake and involvement in personnel and compensation systems. The union has threatened administrative litigation to formally establish Samsung Electronics’ status as an employer.

Recent judicial intervention has impacted the union’s strategy. A Seoul High Court ruling expanded the list of essential processes that must remain operational during strikes—increasing the scope from three to nine critical manufacturing steps—which restricts the union’s ability to halt production lines. Consequently, the union has adjusted its rally schedule while maintaining its intent to pursue collective action.